Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStaying well hydrated on Mounjaro matters because the medicine slows gastric emptying and commonly causes nausea, vomiting, and diarrhoea, all of which can strip fluid from your body faster than you notice. Dehydration on a GLP-1 or dual-agonist medicine is not a minor inconvenience; it can affect your kidneys and compound the very side effects that most people want to avoid. Mounjaro is a prescription-only medicine (suitability is decided by a prescriber after a full clinical assessment, not by a checklist) and how well you manage hydration is one of the practical questions that shapes how comfortably treatment goes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people assume the hydration guidance is boilerplate, something every medicine leaflet says to pad out the instructions. On Mounjaro, it is not. Tirzepatide activates both GIP and GLP-1 receptors, which slows the rate at which your stomach empties. That slowdown is exactly why appetite drops and you feel full on smaller amounts of food. The same mechanism means fluids take longer to clear the stomach too, so sipping steadily throughout the day is usually more comfortable than drinking a large volume at once.
The NHS medicines page for tirzepatide explains that gastrointestinal effects (nausea, vomiting, diarrhoea, constipation) are the most commonly reported side effects, particularly in the first weeks of treatment and again after each dose step. Every episode of vomiting or loose stools removes fluid. If intake does not keep pace, dehydration can develop quietly, and the first signs (a dull headache, darker urine, feeling lightheaded) can be mistaken for the medicine itself rather than a correctable shortfall in water. Staying ahead of that is not a general wellness tip; it is a direct, functional part of managing how treatment feels day to day. Our clinical team emphasises this specifically when patients ask why early weeks can feel harder than expected.
A question our prescribers hear most weeks: "Can I count coffee or tea towards my fluid intake?" In principle, yes, but caffeinated drinks have a mild diuretic effect and can irritate an unsettled stomach, so plain water, herbal teas, and diluted squash tend to sit more comfortably during the first months of treatment.
When nausea or vomiting is severe enough, the risk moves beyond discomfort. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines highlighted that significant gastrointestinal illness (particularly vomiting and diarrhoea) can cause dehydration serious enough to affect kidney function. This is not a common outcome, but it is the reason the guidance is specific: keep fluid intake consistent, recognise early warning signs, and seek medical help promptly if you cannot keep fluids down for more than a day or two.
Dark or infrequent urine is the most reliable early marker to watch for. A dry mouth or persistent headache that arrives around a dose increase, rather than at a fixed time of day, often reflects fluid depletion rather than a side effect of the medicine itself. Bringing fluid intake up steadily (small amounts often) usually resolves it within a few hours if caught early. If it does not, or if vomiting is making it impossible to drink, that warrants a call to your prescriber or, depending on severity, to NHS 111. You can find more on what to monitor across the treatment period on our Mounjaro information page.
People sometimes wonder whether there is such a thing as too much water on treatment. Overhydration is genuinely rare in practice, though it is worth knowing that drinking extreme volumes quickly can cause problems of its own, the guidance on upper limits covers this in more detail for anyone who wants the full picture.
Plain still water is the clearest choice. It does not interact with a slowed stomach or an irritated gut lining, and it leaves no ambiguity about what you are consuming alongside the medicine. That said, variety is not dangerous, the practical goal is consistent fluid intake, not a rigid regime.
Fizzy water sits in a slightly different category. Carbonation can cause bloating and belching, which already feature in some people's side-effect profile on tirzepatide; whether it is a problem depends on individual tolerance rather than any pharmacological interaction. There is more on this in the carbonated water and Mounjaro breakdown, if fizzy drinks are your usual preference.
Alcohol deserves a separate note. It is a diuretic, it lowers inhibitions around food choices, and it can amplify nausea in people whose stomachs are already working more slowly than usual. The detail on drinking alcohol during Mounjaro treatment sets out what the current guidance says and where the practical risks sit. It is not a simple yes or no.
Sports drinks and very sugary squashes are worth limiting too, not because of any direct drug interaction, but because high sugar content can irritate a stomach that is already more sensitive than it was before starting treatment. Diluted options, or drinks with no added sugar, generally sit better. The NHS provides straightforward patient-level information on tirzepatide side effects and practical guidance that is worth reading alongside any advice your prescriber gives you.
The practical goal most prescribers suggest is around 1.5 to 2 litres of fluid a day from all sources, which aligns with general NHS guidance on hydration) though individual needs shift with weather, activity level, and how much fluid is being lost through side effects on any given week. On days after a dose increase, or during a bout of nausea, aiming toward the higher end and checking urine colour is a sensible routine.
A pattern that many people find easier than setting reminders is tying water intake to something already anchored in the day: a glass when the medicine is taken, another before each meal, one mid-morning and mid-afternoon. Spreading it out also tends to suit a stomach that is emptying more slowly, a habit worth reading more about on the hydration and Mounjaro guide.
For anyone considering treatment or mid-way through it and wanting to understand the broader picture (including what weight management treatment involves beyond the injection itself) a conversation with a prescriber is the right place to start. Hydration is one of the more manageable parts of treatment when you know what to watch for, but it works best alongside regular clinical oversight. Cost of treatment is a separate question for many people; an honest overview of Mounjaro pricing in the UK covers what is typically included in a private prescription and what to watch for when comparing providers.
If you have specific questions about hydration, side-effect management, or whether Mounjaro is appropriate for your circumstances, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.